← All trials
NCT04748796
N/AInterventional
Trials without FDA-defined phases, including trials of devices or behavioral interventions.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Feb 1, 2021
- Primary completion
- Feb 28, 2023
- Completion date
- Mar 31, 2023
- First posted
- Feb 10, 2021
- Last posted
- Jul 13, 2021
- Enrollment
- 360
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- University of Picardie Jules VerneLead sponsor
- University of Caen-NormandieCollaborator
- CHU Henri MondorCollaborator
- University of LilleCollaborator
- University of Western BrittanyCollaborator
- Centre Hospitalier Universitaire de NīmesCollaborator
- University of MontpellierCollaborator
- CHU AMBROISE PARECollaborator
- Centre Hospitalier de TourcoingCollaborator
- Sorbonne UniversityCollaborator
- Centre Hospitalier d'ArrasCollaborator
- Hospital AvicenneCollaborator
- Centre Hospitalier de LensCollaborator
- Centre Hospitalier de DouaiCollaborator
- Centre Hospitalier de RoubaixCollaborator
- Centre Hospitalier de BéthuneCollaborator
- Valenciennes Hospital CentreCollaborator
- Centre Hospitalier de CalaisCollaborator
- Centre Hospitalier de CherbourgCollaborator
- Centre Hospitalier COMPIEGNECollaborator
- Centre Hospitalier de DieppeCollaborator
- Centre Hospitalier Intercommunal Elbeuf-Louviers / Val de ReuilCollaborator
- Centre Hospitalier de LaonCollaborator
- Centre Guillaume le Conquerant LE HAVRE FranceCollaborator
- Hôpital Saint Philibert, LommeCollaborator
- CH MontreuilCollaborator
- CHU Edouard HerriotCollaborator
- Centre Hospitalier de BeauvaisCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.